Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    AstraZeneca plc isn’t the only way to play the world’s ageing population

    | Edward Sheldon, CFA

    AstraZeneca plc (LON: AZN) may have long-term potential, but could this 'niche' healthcare stock be a better way to play…

    Read more »

    Investing Articles

    Why AstraZeneca plc shares could be the buy of the decade

    | G A Chester

    AstraZeneca plc's (LON:AZN) share price could double in five years, says G A Chester.

    Read more »

    Investing Articles

    AstraZeneca plc isn’t the only high-growth stock I’d buy today

    | Peter Stephens

    This stock could deliver high returns alongside AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Why I’d buy Neil Woodford’s favourite dividend stock AstraZeneca plc in 2018

    | Rupert Hargreaves

    2018 could be the year that AstraZeneca plc's (LON: AZN) turnaround finally starts to take hold.

    Read more »

    Investing Articles

    A Neil Woodford recovery stock I’d buy alongside AstraZeneca plc

    | Alan Oscroft

    Bolstering the risk of smaller-cap stocks by combining them with giants like AstraZeneca plc (LON: AZN) could be a winning…

    Read more »

    Investing Articles

    AstraZeneca plc isn’t the only pharma stock I’d buy today

    | Royston Wild

    Royston Wild explains why AstraZeneca plc (LON: AZN) could make you a fortune.

    Read more »

    Investing Articles

    Why I’d buy FTSE 100 star Legal & General Group plc as profits set to hit record high

    | Roland Head

    Roland Head explains why Legal & General Group plc (LON:LGEN) is one of his top FTSE 100 (INDEXFTSE:UKX) picks.

    Read more »

    Investing Articles

    Why I’d sell this FTSE 250 flop and buy AstraZeneca plc instead

    | G A Chester

    G A Chester sees a much stronger investment case for AstraZeneca plc (LON:AZN) than this FTSE 250 (INDEXFTSE:MCX) stock.

    Read more »

    Investing Articles

    Is AstraZeneca plc a strong buy after Q3 results?

    | Peter Stephens

    Is AstraZeneca plc (LON: AZN) still on course for a recovery?

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca plc over this soaring growth stock

    | Harvey Jones

    Harvey Jones says AstraZeneca plc (LON: AZN) could hit new peaks and put this biotechnology upstart in its place.

    Read more »

    Investing Articles

    This FTSE 100 growth stock could be a better buy than AstraZeneca plc

    | Edward Sheldon, CFA

    AstraZeneca plc (LON: AZN) is a popular healthcare stock among UK investors. But is this FTSE 100 (INDEXFTSE:UKX) joint replacement…

    Read more »

    Investing Articles

    Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

    | Kevin Godbold

    I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

    Read more »